Segal Trials

Introduction

A functioning alcoholic is someone who suffers from alcohol use disorder (AUD) yet maintains the façade of a normal and successful life. These individuals, often referred to as high-functioning alcoholics, may excel in their personal and professional endeavors while secretly battling alcohol dependency. Recognizing high-functioning alcoholism is crucial, as it doesn't always present the typical signs associated with addiction, rendering the struggle less visible.

Introduction

The holiday season is often depicted as a time of joy and celebration, yet for many, it can be a period marked by heightened emotional challenges. Depression during Christmas and sadness during the holidays are common feelings. These emotions may come from various sources, such as family dynamics, increased stress, and societal pressures.

Introduction

Generalized Anxiety Disorder (GAD) is a common mental health condition characterized by excessive and uncontrollable worry. It affects many individuals, disrupting their daily lives, social interactions, and work activities.

Understanding Flu Symptoms

Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. It affects the nose, throat, and sometimes the lungs, leading to mild to severe illness and even death. Recognizing flu symptoms early on is crucial for effective treatment and prevention. Early detection allows for timely medical intervention and helps prevent spreading the virus to others.

Welcome to Part 2 of our exploration into anxiety. Last year, we discussed common behaviors and symptoms associated with Social Anxiety Disorder in our blog: If You Can Relate, You May Have Social Anxiety Disorder. Today, we delve deeper, offering new insights and the latest information to help you understand this pervasive condition. If you find yourself relating to these experiences, it may be time to consider professional avenues, including potential participation in a clinical trial for anxiety.

Miami Lakes, FL – Segal Trials, a leading clinical research organization specializing in acute schizophrenia trials, has been recognized by the PPD Select Global Partnership Program for outstanding enrollment performance. This accolade was awarded for the site’s exemplary participation in the Phase 2 study of CVL-231 (Emraclidine), aimed at treating patients experiencing an acute exacerbation of psychosis.

[North Miami, FL – [August 21, 2024] – Segal Trials is proud to announce the completion of the first injection procedure in the DigniFI Study. The Women’s Health Team, under the leadership of Principal Investigator Steven Chavoustie, M.D., FACOG and Sub-Investigator Brittany Berre MSN, ARNP, FNP-C, worked diligently to prepare for this vital women's health study. The study's first injection procedure was performed on August 19, 2024.. Segal Trials also completed the first muscle tissue procurement procedure for the study on March 21, 2024.

The FDA's recent decision to pause the approval of MDMA-assisted therapy for PTSD is a reminder of the complexities in advancing groundbreaking treatments. While the...

In the field of medical research, the study of women's health is essential, illuminating unique health needs and leading the way in personalized medicine. Historically, much of medical research has focused on male subjects, leaving gaps in our understanding of female-specific health issues. As we advance in healthcare, the focused study of women’s health and sex differences not only improves our understanding but also drives innovations that promise better health outcomes for everyone. This article explores the significant impact of female-centric clinical studies and highlights the efforts of institutions like Segal Trials to address these critical areas.